ACE and COVID-19: Ace inhibitor drugs and Ang II receptor blockers decrease Ang II effects and thus dampen hypertension and other COVID-19 comorbidities (Rice et al., 2004; Messerli et al., 2018; Natesh et al., 2004; Sommerstein et al., 2020).